Medical information Clinical review pending

Infection Testing

SARS-CoV-2 Respiratory Comprehensive Panel Test

A comprehensive test to detect common respiratory infections, including COVID-19 and H1N1, providing insights into your respiratory health.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Oropharyngeal and nasopharyngeal swabs inoculated in special viral transport medium (VTM).
Results: Confirm with the laboratory before booking.
Preparation: Overnight fasting is preferred. Ensure you have the required clinical information forms (Form 44 for COVID-19, Form 25 for H1N1) completed.

Test priceKSh 49,140

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the SARS-CoV-2 Respiratory Comprehensive Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Presence of respiratory symptoms like fever, cough, or shortness of breath
✓Recent exposure to individuals with confirmed COVID-19 or H1N1
✓Need for differential diagnosis of respiratory illness
✓Monitoring for complications related to respiratory infections
✓Public health surveillance

In plain language

What this test helps you understand

This test helps identify the presence of specific respiratory viruses and provides markers that can indicate the severity of infection or inflammation. It aids in guiding clinical management and infection control measures.

The SARS-CoV-2 Respiratory Comprehensive Panel Test is a vital diagnostic tool designed to detect respiratory infections, including COVID-19 and H1N1. This comprehensive test combines multiple components to provide a thorough analysis of your respiratory health. With the ongoing challenges posed by respiratory viruses, understanding your health status has never been more important. This test measures several key components to assess respiratory infections, including SARS-CoV-2 RT-PCR, CBC (Complete Blood Count), NLR (Neutrophil-Lymphocyte Ratio), CRP (C-Reactive Protein), H1N1 Qualitative RT-PCR, and a Respiratory Comprehensive Panel.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationOvernight fasting is preferred. Ensure you have the required clinical information forms (Form 44 for COVID-19, Form 25 for H1N1) completed.

SampleOropharyngeal and nasopharyngeal swabs inoculated in special viral transport medium (VTM).

MethodologyThe test utilizes various methods including RT-PCR (Reverse Transcription Polymerase Chain Reaction) for viral detection, and standard laboratory techniques for CBC, NLR, and CRP analysis.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific viruses and markers at the time of sample collection. Results may be affected by the timing of sample collection relative to symptom onset, prior vaccination status, or the presence of other infections. A negative result does not completely rule out infection. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

This test detects SARS-CoV-2 (COVID-19) and H1N1 (Swine Flu) viruses, and includes a Complete Blood Count (CBC), Neutrophil-Lymphocyte Ratio (NLR), C-Reactive Protein (CRP), and a Respiratory Comprehensive Panel.

Individuals experiencing respiratory symptoms like fever, cough, or shortness of breath, or those with recent exposure to confirmed cases, should consider this test.

The sample is collected using oropharyngeal and nasopharyngeal swabs placed in a special viral transport medium (VTM).

Overnight fasting is preferred for the most accurate results.

Confirm with the laboratory before booking.

You will need to provide completed Covid-19 Clinical Information Form (Form 44) and Swine Flu/H1N1 Clinical Information Form (Form 25).

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp